NCT01905150 - Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 13, 2014

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions

Pancreatic Cancer

Interventions

DRUG

G-FLIP

G-FLIP is a combination of Low Doses of Gemcitabine, Fluorouracil \[5FU\], Leucovorin, Irinotecan, and Oxaliplatin

DRUG

G-FLIP-DM

G-FLIP-DM is low doses of Gemcitabine, Fluorouracil \[5FU\], Leucovorin, Irinotecan, Oxaliplatin, Docetaxel and Mitomycin C

DIETARY_SUPPLEMENT

Vitamin C

High dose of Vitamin C, used in combination with G-FLIP and then G-FLIP-DM

Trial Locations (1)

Bruckner Oncology, The Bronx